NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

The summary for the NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional): This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).

Federal Grant Title:	NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-21-224
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.853
CFDA Descriptions:	Information not provided
Current Application Deadline:	April 5th, 2024
Original Application Deadline:	April 5th, 2024
Posted Date:	May 5th, 2021
Creation Date:	May 5th, 2021
Archive Date:	May 11th, 2024
Total Program Funding:
Maximum Federal Grant Award:	$1,000,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	January 21st, 2022

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-21-224.html
Grant Announcement Contact: NIH OER Webmaster
grantsinfo@nih.gov
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Development and Validation of Models for Alzheimers Disease-Related Dementias (ADRD) (R61/...; • NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed); • Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial No...; • Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Cli...; • Using Multimodal Biomarkers to Differentially Diagnose ADRDs for Clinical Trials (U19 Clin...; • NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44); • NINDS Institutional Center Core Grants to Support Neuroscience Research; • Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health: • BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R...; • Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorde...; • BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R...; • International Research in Infectious Diseases (R01 Clinical Trial Not Allowed); • Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IM...